Purpose Currently, a number of medications for coronavirus disease 2019 (COVID-19)
treatment are tested in clinical trials; however, credible clinical studies are becoming …

The coronavirus has posed a serious threat to the world since its discovery in Wuhan in
2019. Beta, gamma, delta, and the final omicron variants have emerged as a result of …

A novel severe viral pneumonia emerged in Wuhan city, China, in December 2019. The
spike glycoprotein of the SARS-CoV-2 plays a crucial role in the viral entry to the host cell …

Rapid emergence and evolution of novel SARS-CoV-2 variants has raised concerns about
their potential impact on efficiency of currently available vaccines. Among the most …

Background The new coronavirus is still a life-threatening menace, because of its changing
nature and capacity to produce many mutations to bypass the immune system. The …

Background: The global pandemic of coronavirus disease is a societal, economic, and
publichealth crisis that is still underway. The spike glycoprotein of SARS-CoV-2 is one of the …

Introduction Despite the availability of several COVID-19 vaccines, the incidence of
infections remains a serious issue. Tunicamycin (TM), an antibiotic, inhibited tumor growth …

Аннотация В связи с быстрым развитием и эволюцией новых вариантов SARS-CoV-2
возникли проблемы, касающиеся их потенциального влияния на эффективность …

Аннотация Глобальная пандемия коронавирусной инфекции стала длительной
кризисной ситуацией для общества, экономики и здравоохранения, которая …

Introduction. It is established that the severity of SARS-CoV-2 infections varies between
individuals without underlying health conditions and those with chronic illnesses like …